Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects

Diabetes

Volumn 47, Issue 7, 1998, Pages 1107-1113

  Kruszynska, Yolanta T ^a,b   Mulford, Mim I ^a   Baloga, Joseph ^a   Yu, Joseph G ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXOKINASE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIFFUSION; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENETIC TRANSCRIPTION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MITOCHONDRIAL MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; BLOOD GLUCOSE; CITRATE (SI)-SYNTHASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEXOKINASE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION;

EID: 0031750401     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.7.1107     Document Type: Article

References (57)

1. Kruszynska YT, Olefsky JM: Cellular and molecular mechanisms of non-insulin-dependent diabetes mellitus. J Invest Med 44:413-428, 1996
2. 13C-nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
3. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR: Multiple defects in muscle glycogen synthase contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. J Clin Invest 87:489-495, 1991
4. Bogardus C, Lillioja S, Stone K, Mott D: Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185-1190, 1984
5. James DE, Piper RC: Insulin resistance, diabetes, and the insulin-regulated trafficking of Glut 4. J Cell Biol 126:1123-1126, 1994
6. Braithwaite SS, Palazuk B, Colca JR, Edwards CW, Hofmann C: Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes 44:43-48, 1995
7. Burcelin R, Printz RL, Kande J, Assan R, Granner DK, Girard J: Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. Am J Physiol 265:E392-E401, 1993
8. O'Doherty RM, Bracy DP, Osawa H, Wasserman DH, Granner DK: Rat skeletal muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. Am J Physiol 266:E171-E178, 1994
9. Postic C, Leturque A, Rencurel F, Printz RL, Forest C, Granner DK, Girard J: The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes 42:922-929, 1993
10. Printz RL, Koch S, Potter LR, O'Doherty RM, Tiesinga JJ, Moritz S, Granner DK: Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. J Biol Chem 268:5209-5219, 1993
11. Kelley DE, Mintun MA, Watkins SC, Simoneau J-A, Jadali F, Fredrickson A, Beattie J, Theriault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97:2705-2713, 1996
12. Vestergaard H, Bjorbaek C, Hansen T, Larsen FS, Granner DK, Pedersen O: Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96:2639-2645, 1995
13. Wilson JE: Hexokinases. Rev Physiol Biochem Pharmacol 126:65-174, 1994
14. Mandarino LJ, Printz RL, Cusi KA, Kinchington P, O'Doherty RM, Osawa H, Sewell C, Consoli A, Granner DK, DeFronzo RA: Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol 269:E701-E708, 1995
15. Tsao T-S, Burcelin R, Charron MJ: Regulation of hexokinase II gene expression by glucose flux in skeletal muscle. J Biol Chem 271:14959-14963, 1996
16. Frank SK, Fromm HJ: Effect of streptozotocin-induced diabetes and insulin treatment on the synthesis of hexokinase II in the skeletal muscle of the rat. Arch Biochem Biophys 249:61-69, 1986
17. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727), p. 80-82
18. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
19. Bergstrom J: Muscle electrolytes in man determined by neutron activation analysis on needle biopsy specimen: a study on normal subjects, kidney patients, and patients with chronic diarrhea. Scand J Clin Lab Invest 14 (Suppl. 68):1-110, 1962
20. Kruszynska YT, Mulford Ml, Yu JG, Armstrong DA, Olefsky JM: Effects of non-esterified fatty acids on glucose metabolism after glucose ingestion. Diabetes 46:1586-1593, 1997
21. Ferrannini E: The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301, 1988
22. Jequier E, Felber J-P: Indirect calorimetry. In Techniques for Metabolic Investigation in Man: Bailliere's Clinics in Endocrinology and Metabolism. Vol. 1, part 1. Alberti KGMM, Home PD, Taylor R, Eds. London, Bailliere-Tindall, 1987, p. 911-935
23. Frayn KN: Calculation of substrate oxidation rate in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
24. Coore HG, Denton RM, Martin BR, Randle PJ: Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem J 125:115-127, 1971
25. Grossbard L, Schimke RT: Multiple hexokinases of rat tissues: purification and comparison of soluble forms. J Biol Chem 241:3546-3560, 1966
26. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72:246-254, 1976
27. Somogyi MJ: Determination of blood sugar. J Biol Chem 160:69-73, 1945
28. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738, 1971
29. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430, 1959
30. Wolfe RR: Tracers in Metabolic Research: Radioisotope/Mass Spectrometry Methods. New York, Liss, 1084, p. 81-101
31. 31P-nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non- insulin-dependent diabetes mellitus. J Clin Invest 89:1069-1075, 1992
32. Zierath JR, He L, Guma A, Wahlstrom EO, Klip A, Wallberg-Henriksson H: Insulin action on glucose transport and plasma membrane Glut 4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996
33. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92:486-494, 1993
34. Osawa H, Sutherland C, Robey RB, Prints RL, Granner DK Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin. J Biol Chem 271:16690-16694, 1996
35. Rogers PA, Fisher RA, Harris H: An electrophoretic study of the distribution and properties of human hexokinases. Biochem Genet 13:857-866, 1975
36. Vogt C, Iozzo P, Pipek R, Yki-Jarvinen H, Printz R, Ardehali H, Granner D, Mandarino L: Insulin alters the subcellular distribution of hexokinase II (HKII) activity in human skeletal muscle (Abstract). Diabetes 45 (Suppl. 2):19A, 1996
37. Bernstein RS, Kipnis DM: Regulation of rat hexokinase isoenzymes. I. Assay and effect of age, fasting and refeeding. Diabetes 22:913-922, 1973
38. Fink RI, Wallace P, Brechtel G, Olefsky JM: Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 41:897-902, 1992
39. Furier SM, Jenknis AB, Storlien LH, Kraegen EW: In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. Am J Physiol 261:E387-E347, 1991
40. Katz A, Nyomba BL, Bogardus C: No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am J Physiol 255:E942-E945, 1988
41. Kubo K, Foley JE: Rate-limiting steps for insulin-mediated glucose uptake into perfused rat hindlimb. Am J Physiol 250:E100-E102, 1986
42. Ren JM, Marshall BA, Gulve EA, Gao J, Johnson DW, Holloszy JO, Mueckler M: Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem 268:16113-16115, 1993
43. Chang P-Y, Jensen J, Printz RL, Granner DK Ivy JL, Moller DE: Overexpression of hexokinase II in transgenic mice: evidence that increased phosphorylation augments muscle glucose uptake. J Biol Chem 271:14834-14839, 1996
44. Gregoriou M, Trayer IP, Cornish-Bowden A: Allosteric character of the inhibition of rat muscle hexokinase B by glucose-6-phosphate. Eur J Biochem 161:171-176, 1986
45. Lynch RM, Carrington W, Fogarty KE, Fay FS: Metabolic modulation of hexokinase association with mitochondria in living smooth muscle cells. Am J Physiol 270:C488-C499, 1996
46. Seely BL, Olefsky JM: Potential cellular and genetic mechanisms for insulin resistance in the common disorders of obesity and diabetes. In Insulin Resistance and Its Clinical Disorders. Moller D, Ed. Chichester, U.K., Wiley, 1993, p. 187-252
47. Newsholme EA, Crabtree B, Zammit VA: Use of enzyme activities as indices of maximum rates of fuel utilization. CIBA Foundation Symp 73:245-258, 1980
48. Howald H, Pette D, Simoneau J-A, Uber A, Hoppeler H, Corretelli P: Effects of chronic hypoxia on muscle enzyme activities. Int J Sports Med 11 (Suppl. 1):S10-S14, 1990
49. Simoneau J-A, Colberg SR, Thaete FL, Kelley DE: Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 9:273-278, 1995
50. Colberg SR, Simoneau J-A, Thaete FL, Kelley DE: Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853, 1995
51. Simoneau J-A, Kelley DE: Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166-171, 1997
52. Kriketos AD, Pan DA, Sutton JR, Hoh JFY, Baur LA, Cooney GJ, Jenkins AB, Storlien LH: Relationships between muscle membrane lipids, fiber type, and enzyme activities in sedentary and exercised rats. Am J Physiol 269:R1154-R1162, 1995
53. Simoneau JA, Lortie G, Boulay MR, Thibault MC, Theriault G, Bouchard C: Skeletal muscle histochemical and biochemical characteristics in sedentary male and female subjects. Can J Physiol Pharm 63:30-35, 1985
54. Wade AJ, Marbut MM, Round JM: Muscle fibre type and aetiology of obesity. Lancet 335:805-808, 1990
55. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott GH, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fibre type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80:415-424, 1987
56. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, Dohm GL: Skeletal muscle fiber type composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol 268:E453-E457, 1995
57. Marin P, Andersson B, Krotkiewski M, Bjorntorp P: Muscle fiber composition and capillary density in women with NIDDM. Diabetes Care 17:383-386, 1994